Jacob Plieth
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@madeleinewrite.bsky.social
Writer, runner, trying to keep up with another social media platform
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@biotechmiller.bsky.social
20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing communications and strategy at Curevo Vaccine. Avid sailor who races. All views are my own. What are you doing with your one wild and precious life? (Mary Oliver)
@raffcolo.bsky.social
ADCs, targeted therapies, chemistry, biotech, pharma. Associate Director @ Zymeworks
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@bllphd.bsky.social
🧬🧪Professor @Pennmedicine #CellTherapy #Genetherapy #Inventor #Kymriah #CARTCell @TmunityTx & @CapstanTx CoFounder, Past President @ISCTGlobal @PNASNexus AE https://orcid.org/0000-0001-6971-8465
@geneman10.bsky.social
| Genetics PhD | Likes, posts, reposts are my own | Global Head, Oncology Search and Evaluation - Daiichi Sankyo BD
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@drsam.bsky.social
Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV. I'm also at https://substack.com/@drsamblackman
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.